Sunmax Biotechnology Co., Ltd.

TPEX:4728 Stock Report

Market Cap: NT$15.0b

Sunmax Biotechnology Balance Sheet Health

Financial Health criteria checks 6/6

Sunmax Biotechnology has a total shareholder equity of NT$1.4B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.9B and NT$500.5M respectively. Sunmax Biotechnology's EBIT is NT$913.5M making its interest coverage ratio -84.9. It has cash and short-term investments of NT$653.5M.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ratio-84.9x
CashNT$653.50m
EquityNT$1.37b
Total liabilitiesNT$500.52m
Total assetsNT$1.87b

Recent financial health updates

No updates

Recent updates

Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

Feb 28
Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

Feb 02
Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 20
Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

Nov 24
Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

Financial Position Analysis

Short Term Liabilities: 4728's short term assets (NT$851.6M) exceed its short term liabilities (NT$250.7M).

Long Term Liabilities: 4728's short term assets (NT$851.6M) exceed its long term liabilities (NT$249.8M).


Debt to Equity History and Analysis

Debt Level: 4728 is debt free.

Reducing Debt: 4728 had no debt 5 years ago.

Debt Coverage: 4728 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 4728 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 00:20
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sunmax Biotechnology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.